Related Experiment Video
Updated: May 29, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Coronary artery calcium: utilization for primary prevention of CHD
Insights
Coronary artery calcium (CAC) is the premier cardiac risk predictor in asymptomatic individuals. CAC guides risk reduction by identifying targets, making it the most cost-effective primary prevention strategy.
Area of Science:
- Cardiology
- Preventive Medicine
- Medical Imaging
Background:
- Coronary artery calcium (CAC) scoring is emerging as a pivotal tool in cardiovascular risk assessment.
- Traditional risk factors are re-evaluated in light of CAC's predictive power.
Discussion:
- CAC surpasses traditional risk factors in predicting cardiac events in asymptomatic populations.
- Risk factors are best utilized to identify targets for intervention once CAC has established risk.
- Population-based "normal" cholesterol levels lack individual patient relevance.
Key Insights:
- Subclinical atherosclerosis, measured by serial CAC, is superior to lipid values for defining residual and pretreatment risk.
- CAC screening implementation does not require prior randomized controlled trials.
- Lipid-lowering drug trials should exclude individuals with zero CAC.
Outlook:
- CAC represents the most cost-effective approach to primary cardiovascular prevention.
- Future cardiovascular risk assessment and prevention strategies will likely be centered around CAC imaging.
- Personalized medicine in cardiology is advanced by CAC's individual risk stratification capabilities.
Abstract:
The rapidly accumulating data supporting coronary artery calcium (CAC) has necessitated multiple paradigm shifts in primary prevention: 1) CAC is the most powerful predictor of cardiac risk in the asymptomatic primary prevention population. 2) The most important role of risk factors may be to identify the modifiable targets of risk reduction in patients with risk already established by CAC. 3) "Normal cholesterol" values derived from population-based studies are not relevant for individual patients. 4) Measures of subclinical atherosclerosis (ie, serial CAC), rather than lipid values, define residual risk just as they define pretreatment risk. 5) Randomized controlled trials are not a prerequisite for implementation of CAC screening. 6) Trials evaluating lipid-treating drugs should exclude patients with 0 CAC. 7) CAC is the most cost-effective primary prevention approach.
More Related Videos
06:57Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images
Published on: September 22, 2023
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System V: CT